- Corporate Officers - B
- Butitta Cynthia M
Insider Trading History of Butitta Cynthia M
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Butitta Cynthia M since 2015.
This trader's CIK number is 1222082.
At the time of last reporting, Butitta Cynthia M was the Director of Urogen Pharma Ltd.. (stock ticker symbol URGN).
Also see all insider trading activities at Urogen Pharma Ltd..
Note that in the past
BUTITTA CYNTHIA M also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Olema Pharmaceuticals, Inc. (OLMA) by Butitta Cynthia M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | OLMA | 0 | $0 | 0 | $0 | 83,876 | $369,557 |
Yearly summary of insider trading at Urogen Pharma Ltd. (URGN) by Butitta Cynthia M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | URGN | 0 | $0 | 0 | $0 | 2,000 | $0 |
Yearly summary of insider trading at Kite Pharma, Inc. (KITE) by Butitta Cynthia M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | KITE | 0 | $0 | 159,228 | $13,494,261 | 150,000 | $202,499 |
| 2016 | KITE | 0 | $0 | 102,482 | $5,311,089 | 100,000 | $135,000 |
| 2015 | KITE | 0 | $0 | 100,000 | $6,504,045 | 90,000 | $121,500 |
Insider trading activities at 3 companies by Butitta Cynthia M:
1. Olema Pharmaceuticals, Inc. (OLMA)
2. Urogen Pharma Ltd. (URGN)
3. Kite Pharma, Inc. (KITE)
Table 1. Insider trading of Olema Pharmaceuticals, Inc. (OLMA) by Butitta Cynthia M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-09-16 | OLMA | Option Ex | 83,876 | 4.41 | 369,557 |
Table 2. Insider trading of Urogen Pharma Ltd. (URGN) by Butitta Cynthia M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-11-26 | URGN | Option Ex | 2,000 | .00 | 0 |
Table 3. Insider trading of Kite Pharma, Inc. (KITE) by Butitta Cynthia M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-09-25 | KITE | Sale | 4,228 | 179.66 | 759,619 |
| 2017-08-10 | KITE | Option Ex | 15,000 | 1.35 | 20,250 |
| 2017-08-10 | KITE | Sale | 15,000 | 120.78 | 1,811,625 |
| 2017-07-10 | KITE | Option Ex | 15,000 | 1.35 | 20,250 |
| 2017-07-10 | KITE | Sale | 15,000 | 102.89 | 1,543,350 |
| 2017-06-23 | KITE | Sale | 5,000 | 100.86 | 504,325 |
| 2017-06-09 | KITE | Sale | 10,000 | 88.16 | 881,600 |
| 2017-06-09 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
| 2017-04-25 | KITE | Option Ex | 15,000 | 1.35 | 20,250 |
| 2017-04-25 | KITE | Sale | 15,000 | 81.97 | 1,229,505 |
| 2017-04-03 | KITE | Sale | 5,000 | 82.69 | 413,440 |
| 2017-04-03 | KITE | Option Ex | 5,000 | 1.35 | 6,750 |
| 2017-03-27 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
| 2017-03-27 | KITE | Sale | 10,000 | 77.45 | 774,550 |
| 2017-03-09 | KITE | Option Ex | 21,118 | 1.35 | 28,509 |
| 2017-03-09 | KITE | Sale | 21,118 | 80.83 | 1,707,073 |
| 2017-02-27 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
| 2017-03-01 | KITE | Option Ex | 28,882 | 1.35 | 38,990 |
| 2017-02-27 | KITE | Sale | 10,000 | 55.03 | 550,320 |
| 2017-03-01 | KITE | Sale | 28,882 | 80.05 | 2,312,004 |
| 2017-01-31 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
| 2017-01-31 | KITE | Sale | 10,000 | 50.56 | 505,560 |
| 2017-01-06 | KITE | Sale | 10,000 | 50.13 | 501,290 |
| 2017-01-06 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
| 2016-12-20 | KITE | Sale | 2,482 | 50.86 | 126,234 |
| 2016-11-25 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
| 2016-11-25 | KITE | Sale | 10,000 | 50.90 | 508,950 |
| 2016-11-10 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
| 2016-11-10 | KITE | Sale | 10,000 | 50.95 | 509,450 |
| 2016-09-26 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
| 2016-09-26 | KITE | Sale | 10,000 | 54.13 | 541,300 |
| 2016-08-25 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
| 2016-08-25 | KITE | Sale | 10,000 | 58.52 | 585,250 |
| 2016-07-25 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
| 2016-07-25 | KITE | Sale | 10,000 | 50.94 | 509,350 |
| 2016-06-27 | KITE | Sale | 10,000 | 50.15 | 501,480 |
| 2016-06-27 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
| 2016-06-23 | KITE | Sale | 10,000 | 51.27 | 512,750 |
| 2016-06-23 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
| 2016-04-04 | KITE | Sale | 10,000 | 50.00 | 500,000 |
| 2016-04-04 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
| 2016-03-01 | KITE | Sale | 10,000 | 50.03 | 500,300 |
| 2016-03-01 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
| 2016-02-02 | KITE | Option Ex | 1,900 | 1.35 | 2,565 |
| 2016-02-02 | KITE | Sale | 1,900 | 50.13 | 95,247 |
| 2016-01-27 | KITE | Option Ex | 8,100 | 1.35 | 10,935 |
| 2016-01-27 | KITE | Sale | 8,100 | 51.95 | 420,778 |
| 2015-12-28 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
| 2015-12-28 | KITE | Sale | 10,000 | 61.70 | 616,950 |
| 2015-11-27 | KITE | Sale | 15,000 | 86.62 | 1,299,375 |
| 2015-11-27 | KITE | Option Ex | 15,000 | 1.35 | 20,250 |
| 2015-11-10 | KITE | Option Ex | 5,000 | 1.35 | 6,750 |
| 2015-11-10 | KITE | Sale | 5,000 | 80.00 | 400,000 |
| 2015-10-27 | KITE | Sale | 10,000 | 70.26 | 702,570 |
| 2015-10-27 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
| 2015-09-28 | KITE | Sale | 10,000 | 55.78 | 557,800 |
| 2015-09-28 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
| 2015-08-27 | KITE | Sale | 10,000 | 53.60 | 536,000 |
| 2015-08-27 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
| 2015-07-27 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
| 2015-07-27 | KITE | Sale | 10,000 | 68.55 | 685,450 |
| 2015-06-29 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
| 2015-06-29 | KITE | Sale | 10,000 | 59.88 | 598,770 |
| 2015-05-27 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
| 2015-05-27 | KITE | Sale | 10,000 | 50.95 | 509,510 |
| 2015-04-27 | KITE | Sale | 10,000 | 59.76 | 597,620 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Butitta Cynthia M
(Director of Urogen Pharma Ltd. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.